Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells

The adaptation of malignancy to therapy presents a significant challenge in cancer treatment. The cell cycle plays a crucial role in regulating the evolution of radio- and chemo-resistance in tumor cells. Cancer stem cells (CSCs) are the primary source of therapy resistance, with CD133 being one of...

Full description

Saved in:
Bibliographic Details
Main Authors: Luyao Wu, Takanori Katsube, Xiaofei Li, Bing Wang, Yi Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2025.1509675/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832087423623888896
author Luyao Wu
Luyao Wu
Takanori Katsube
Xiaofei Li
Bing Wang
Yi Xie
author_facet Luyao Wu
Luyao Wu
Takanori Katsube
Xiaofei Li
Bing Wang
Yi Xie
author_sort Luyao Wu
collection DOAJ
description The adaptation of malignancy to therapy presents a significant challenge in cancer treatment. The cell cycle plays a crucial role in regulating the evolution of radio- and chemo-resistance in tumor cells. Cancer stem cells (CSCs) are the primary source of therapy resistance, with CD133 being one of the most recognized and valuable cell surface markers of CSCs. Evidence increasingly suggests that CD133 is associated with cancer resistance. The current understanding of the molecular biological function of CD133 is limited, leading to ongoing debates about its role in cancer biology. In this review, we explore recent research and emerging trends related to CD133 through extensive literature and content analysis. It was summarized that new insights into the relationships of CD133 and cell cycle signaling pathways in resistant CSCs. The aim of this review is to provide a foundational understanding of how these signaling pathways and their interactions impact cancer prognosis and inform treatment strategies.
format Article
id doaj-art-d2be8092dca0458cab0401d5f262b539
institution Kabale University
issn 2296-2565
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj-art-d2be8092dca0458cab0401d5f262b5392025-02-06T05:21:40ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-02-011310.3389/fpubh.2025.15096751509675Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cellsLuyao Wu0Luyao Wu1Takanori Katsube2Xiaofei Li3Bing Wang4Yi Xie5Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, ChinaGraduate School of the Chinese Academy of Sciences, Beijing, ChinaInstitute for Radiological Science, National Institutes for Quantum Science and Technology, Chiba, JapanGansu Nuclear and Radiation Safety Center, Lanzhou, ChinaInstitute for Radiological Science, National Institutes for Quantum Science and Technology, Chiba, JapanInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, ChinaThe adaptation of malignancy to therapy presents a significant challenge in cancer treatment. The cell cycle plays a crucial role in regulating the evolution of radio- and chemo-resistance in tumor cells. Cancer stem cells (CSCs) are the primary source of therapy resistance, with CD133 being one of the most recognized and valuable cell surface markers of CSCs. Evidence increasingly suggests that CD133 is associated with cancer resistance. The current understanding of the molecular biological function of CD133 is limited, leading to ongoing debates about its role in cancer biology. In this review, we explore recent research and emerging trends related to CD133 through extensive literature and content analysis. It was summarized that new insights into the relationships of CD133 and cell cycle signaling pathways in resistant CSCs. The aim of this review is to provide a foundational understanding of how these signaling pathways and their interactions impact cancer prognosis and inform treatment strategies.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1509675/fullmalignancycancer stem cellsCD133radio- and chemo-resistancecell cycle
spellingShingle Luyao Wu
Luyao Wu
Takanori Katsube
Xiaofei Li
Bing Wang
Yi Xie
Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
Frontiers in Public Health
malignancy
cancer stem cells
CD133
radio- and chemo-resistance
cell cycle
title Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
title_full Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
title_fullStr Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
title_full_unstemmed Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
title_short Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells
title_sort unveiling the impact of cd133 on cell cycle regulation in radio and chemo resistance of cancer stem cells
topic malignancy
cancer stem cells
CD133
radio- and chemo-resistance
cell cycle
url https://www.frontiersin.org/articles/10.3389/fpubh.2025.1509675/full
work_keys_str_mv AT luyaowu unveilingtheimpactofcd133oncellcycleregulationinradioandchemoresistanceofcancerstemcells
AT luyaowu unveilingtheimpactofcd133oncellcycleregulationinradioandchemoresistanceofcancerstemcells
AT takanorikatsube unveilingtheimpactofcd133oncellcycleregulationinradioandchemoresistanceofcancerstemcells
AT xiaofeili unveilingtheimpactofcd133oncellcycleregulationinradioandchemoresistanceofcancerstemcells
AT bingwang unveilingtheimpactofcd133oncellcycleregulationinradioandchemoresistanceofcancerstemcells
AT yixie unveilingtheimpactofcd133oncellcycleregulationinradioandchemoresistanceofcancerstemcells